NAJČEŠĆE KONTRAINDIKACIJE ZA IZVOĐENJE REFRAKTIVNE HIRURGIJE

  • Maja Zivkovic Ocna klinika, KC Nis
  • Marko Zlatanović Medicinski fakultet Univerziteta u Nišu, UKC Niš Klinika za oftalmologiju
  • Nevena Zlatanović Dom zdravlja Niš, odeljene za oftalmologiju, Niš
  • Mladen Brzaković Specijalna bolnica za oftalmologiju Klinika Maja, Niš, Srbija
  • Aleksandra Hristov Specijalna bolnica za oftalmologiju Klinika Maja, Niš, Srbija
Ključne reči: zakrivljenost rožnjače, debljina rožnjače, LASIK, PRK, refraktivna hirurgija

Sažetak


Preoperativni pregled za refraktivnu hirurgiju izuzetno je važan za osiguranje optimalnog ishoda i sprečavanje komplikacija.

Cilj rada jeste da navede najčešće kontraindikacije za refraktivnu hirurgiju, laser-in-situ keratomileuzis (LASIK) i fotorefraktivnu keratektomiju (PRK).

U studiji su obuhvaćeni bolesnici u procesu preoperativnog pregleda za refraktivnu hirurgiju. Svi bolesnici prošli su kompletan oftalmološki pregled, kao i topografiju rožnjače i biometriju oka. Dodatni pregledi izvedeni su u slučajevima sumnje na specifičnu očnu ili sistemsku bolest.

Od 1238 bolesnika (646 muškaraca i 592 žene, srednja starost 32 godine ± 10,4 godine), operacija refraktivne hirurgije obavljena je kod 743 bolesnika (60%), LASIK kod 367 (30%) i PRK kod 376 bolesnika (30%). Refraktivna hirurgija bila je kontraindikovana kod 327 bolesnika (26%), dok su 102 bolesnika otkazala operaciju. Najčešće kontraindikcije za operaciju bile su: nepravilna rožnjača kod 106 bolesnika (32%), previše strma ili suviše ravna zakrivljenost rožnjače kod 71 bolesnika (22%), nedovoljna debljina rožnjače kod 62 bolesnika (19%), visoka miopija kod 28 bolesnika (9%), visoka hipermetropija kod 19 bolesnika (6%), suvo oko kod 13 bolesnika (4%), početna katarakta kod 10 bolesnika (3%) i manje česte očne i sistemske bolesti kod 18 bolesnika (6%).

Na osnovu dobijenih rezultata može se zaključiti da su neregularna topografija rožnjače, zakrivljenost rožnjače i nedovoljna debljina rožnjače najčešće kontraindikacije za refraktivnu hirurgiju.

Reference

800x600

Normal

0

false

false

false

EN-US

X-NONE

X-NONE

DefSemiHidden="false" DefQFormat="false" DefPriority="99"

LatentStyleCount="371">

UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>

Name="index 1"/>

Name="index 2"/>

Name="index 3"/>

Name="index 4"/>

Name="index 5"/>

Name="index 6"/>

Name="index 7"/>

Name="index 8"/>

Name="index 9"/>

UnhideWhenUsed="true" Name="toc 1"/>

UnhideWhenUsed="true" Name="toc 2"/>

UnhideWhenUsed="true" Name="toc 3"/>

UnhideWhenUsed="true" Name="toc 4"/>

UnhideWhenUsed="true" Name="toc 5"/>

UnhideWhenUsed="true" Name="toc 6"/>

UnhideWhenUsed="true" Name="toc 7"/>

UnhideWhenUsed="true" Name="toc 8"/>

UnhideWhenUsed="true" Name="toc 9"/>

Name="Normal Indent"/>

Name="footnote text"/>

Name="annotation text"/>

Name="header"/>

Name="footer"/>

Name="index heading"/>

UnhideWhenUsed="true" QFormat="true" Name="caption"/>

Name="table of figures"/>

Name="envelope address"/>

Name="envelope return"/>

Name="footnote reference"/>

Name="annotation reference"/>

Name="line number"/>

Name="page number"/>

Name="endnote reference"/>

Name="endnote text"/>

Name="table of authorities"/>

Name="macro"/>

Name="toa heading"/>

Name="List"/>

Name="List Bullet"/>

Name="List Number"/>

Name="List 2"/>

Name="List 3"/>

Name="List 4"/>

Name="List 5"/>

Name="List Bullet 2"/>

Name="List Bullet 3"/>

Name="List Bullet 4"/>

Name="List Bullet 5"/>

Name="List Number 2"/>

Name="List Number 3"/>

Name="List Number 4"/>

Name="List Number 5"/>

Name="Closing"/>

Name="Signature"/>

UnhideWhenUsed="true" Name="Default Paragraph Font"/>

UnhideWhenUsed="true" Name="Body Text"/>

Name="Body Text Indent"/>

Name="List Continue"/>

Name="List Continue 2"/>

Name="List Continue 3"/>

Name="List Continue 4"/>

Name="List Continue 5"/>

Name="Message Header"/>

Name="Salutation"/>

Name="Date"/>

Name="Body Text First Indent"/>

Name="Body Text First Indent 2"/>

Name="Note Heading"/>

Name="Body Text 2"/>

Name="Body Text 3"/>

Name="Body Text Indent 2"/>

Name="Body Text Indent 3"/>

Name="Block Text"/>

Name="Hyperlink"/>

Name="FollowedHyperlink"/>

Name="Document Map"/>

Name="Plain Text"/>

Name="E-mail Signature"/>

Name="HTML Top of Form"/>

Name="HTML Bottom of Form"/>

Name="Normal (Web)"/>

Name="HTML Acronym"/>

Name="HTML Address"/>

Name="HTML Cite"/>

Name="HTML Code"/>

Name="HTML Definition"/>

Name="HTML Keyboard"/>

Name="HTML Preformatted"/>

Name="HTML Sample"/>

Name="HTML Typewriter"/>

Name="HTML Variable"/>

Name="Normal Table"/>

Name="annotation subject"/>

Name="No List"/>

Name="Outline List 1"/>

Name="Outline List 2"/>

Name="Outline List 3"/>

Name="Table Simple 1"/>

Name="Table Simple 2"/>

Name="Table Simple 3"/>

Name="Table Classic 1"/>

Name="Table Classic 2"/>

Name="Table Classic 3"/>

Name="Table Classic 4"/>

Name="Table Colorful 1"/>

Name="Table Colorful 2"/>

Name="Table Colorful 3"/>

Name="Table Columns 1"/>

Name="Table Columns 2"/>

Name="Table Columns 3"/>

Name="Table Columns 4"/>

Name="Table Columns 5"/>

Name="Table Grid 1"/>

Name="Table Grid 2"/>

Name="Table Grid 3"/>

Name="Table Grid 4"/>

Name="Table Grid 5"/>

Name="Table Grid 6"/>

Name="Table Grid 7"/>

Name="Table Grid 8"/>

Name="Table List 1"/>

Name="Table List 2"/>

Name="Table List 3"/>

Name="Table List 4"/>

Name="Table List 5"/>

Name="Table List 6"/>

Name="Table List 7"/>

Name="Table List 8"/>

Name="Table 3D effects 1"/>

Name="Table 3D effects 2"/>

Name="Table 3D effects 3"/>

Name="Table Contemporary"/>

Name="Table Elegant"/>

Name="Table Professional"/>

Name="Table Subtle 1"/>

Name="Table Subtle 2"/>

Name="Table Web 1"/>

Name="Table Web 2"/>

Name="Table Web 3"/>

Name="Balloon Text"/>

Name="Table Theme"/>

Name="List Paragraph"/>

Name="Intense Quote"/>

Name="Subtle Emphasis"/>

Name="Intense Emphasis"/>

Name="Subtle Reference"/>

Name="Intense Reference"/>

UnhideWhenUsed="true" Name="Bibliography"/>

UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>

Name="Grid Table 1 Light Accent 1"/>

Name="Grid Table 6 Colorful Accent 1"/>

Name="Grid Table 7 Colorful Accent 1"/>

Name="Grid Table 1 Light Accent 2"/>

Name="Grid Table 6 Colorful Accent 2"/>

Name="Grid Table 7 Colorful Accent 2"/>

Name="Grid Table 1 Light Accent 3"/>

Name="Grid Table 6 Colorful Accent 3"/>

Name="Grid Table 7 Colorful Accent 3"/>

Name="Grid Table 1 Light Accent 4"/>

Name="Grid Table 6 Colorful Accent 4"/>

Name="Grid Table 7 Colorful Accent 4"/>

Name="Grid Table 1 Light Accent 5"/>

Name="Grid Table 6 Colorful Accent 5"/>

Name="Grid Table 7 Colorful Accent 5"/>

Name="Grid Table 1 Light Accent 6"/>

Name="Grid Table 6 Colorful Accent 6"/>

Name="Grid Table 7 Colorful Accent 6"/>

Name="List Table 1 Light Accent 1"/>

Name="List Table 6 Colorful Accent 1"/>

Name="List Table 7 Colorful Accent 1"/>

Name="List Table 1 Light Accent 2"/>

Name="List Table 6 Colorful Accent 2"/>

Name="List Table 7 Colorful Accent 2"/>

Name="List Table 1 Light Accent 3"/>

Name="List Table 6 Colorful Accent 3"/>

Name="List Table 7 Colorful Accent 3"/>

Name="List Table 1 Light Accent 4"/>

Name="List Table 6 Colorful Accent 4"/>

Name="List Table 7 Colorful Accent 4"/>

Name="List Table 1 Light Accent 5"/>

Name="List Table 6 Colorful Accent 5"/>

Name="List Table 7 Colorful Accent 5"/>

Name="List Table 1 Light Accent 6"/>

Name="List Table 6 Colorful Accent 6"/>

Name="List Table 7 Colorful Accent 6"/>

/* Style Definitions */

table.MsoNormalTable

{mso-style-name:"Table Normal";

mso-tstyle-rowband-size:0;

mso-tstyle-colband-size:0;

mso-style-noshow:yes;

mso-style-priority:99;

mso-style-parent:"";

mso-padding-alt:0in 5.4pt 0in 5.4pt;

mso-para-margin:0in;

mso-para-margin-bottom:.0001pt;

mso-pagination:widow-orphan;

font-size:10.0pt;

font-family:"Times New Roman","serif";}

1.   Bamashmus M, Hubaish K, Alawad M, Alakhlee H. Functional Outcome and Patient Satisfaction after Laser In Situ Keratomileusis for Correction of Myopia and Myopic Astigmatism. Middle East Afr J Ophthalmol 2015; 22: 108–14. [CrossRef] [PubMed]

2.   Solomon KD, Fernández de Castro LE, Sandoval HP, Biber JM, Groat B, Neff KD, et al. LASIK world literature review: Quality of life and patient satisfaction.  Ophthalmology   2009; 116: 691–7 01. [CrossRef] [PubMed]

3.   Tahzib NG, Bootsma SJ, Eggink FA, Nabar VA, Nuijts RM. Functional outcomes and patient satisfaction after laser in situ keratomileusis for correction of myopia. J Cataract Refract Surg 2005; 31: 1943–51. [CrossRef] [PubMed]

4.   Lazon de la Jara P, Erickson D, Erickson P, Stapleton F. Visual and nonvisual factors associated with patient satisfaction and quality of life in LASIK. Eye. 2011; 25: 1194–01.  [CrossRef] [PubMed]

5.   Bailey MDMitchell GLDhaliwal DKWachler BSOlson MDShovlin JP, et al. Reasons patients recommend laser in situ keratomileusis. J Cataract Refract Surg  2004; 30: 1861–66. [CrossRef] [PubMed]

6.   Sutton G, Lawless M, Hodge C. Laser in situ keratomileusis in 2012: a review. Clin Exp Optom 2014; 97: 18–29. [CrossRef] [PubMed]

7.   Price MO, Price DA, Bucci FA Jr, Durrie DS, Bond WI, Price FW Jr. Three-Year Longitudinal Survey Comparing Visual Satisfaction with LASIK and Contact Lenses. Ophthalmology 2016; 123: 1659–66. [CrossRef] [PubMed]

8.   Santhiago MR, Smadja D, Wilson SE, Krueger RR, Monteiro ML, Randleman JB. Role of percent tissue altered on ectasia after LASIK in eyes with suspicious topography. J Refract Surg 2015; 31: 258–65. [CrossRef] [PubMed]

9.   Randleman JB, Shah RD. LASIK interface complications: etiology, management, and outcomes. J Refract Surg 2012; 28: 575–86. [CrossRef] [PubMed]

10. Henry CR, Canto AP, Galor A, Vaddavalli PK, Culbertson WW, Yoo SH. Epithelial ingrowth after LASIK: clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift. J Refract Surg 2012; 28: 488–92. [CrossRef] [PubMed]

11. De Paula FH, Khairallah CG, Niziol LM, Musch DC, Shtein RM. Diffuse lamellar keratitis after laser in situ keratomileusis with femtosecond laser flap creation. J Cataract Refract Surg 2012; 38: 1014–9. [CrossRef] [PubMed]

12. Gritz DC. LASIK interface keratitis: epidemiology, diagnosis and care. Curr Opin Ophthalmol 2011; 22: 251–255. [CrossRef] [PubMed]

13. Al-Farhan HM, Al-Otaibi WM. Comparison of central corneal thickness measurements using ultrasound pachymetry, ultrasound biomicroscopy, and the Artemis-2 VHF scanner in normal eyes. Clin Ophthalmol 2012; 6: 103743. [CrossRef] [PubMed]

14. Guilbert E, Saad A, Grise-Dulac A, Gatinel D. Corneal thickness, curvature, and elevation readings in normal corneas: combined Placido-Scheimpflug system versus combined Placido-scanning-slit system. J Cataract Refract Surg  2012; 38: 119806. [CrossRef] [PubMed]

15. Seiler T, Koufala K, Richter G. Iatrogenic keratectasia after laser in situ keratomileusis. J Refract Surg 1998; 14: 312–17. [CrossRef] [PubMed]

16. Randleman JB, Woodward M, Lynn MJ, Stulting RD. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology 2008; 115:37–50. [CrossRef] [PubMed]

17. Moshirfar M, Smedley JG, Muthappan V, Jarsted A, Ostler EM. Rate of ectasia and incidence of irregular topography in patients with unidentified preoperative risk factors undergoing femtosecond laser-assisted LASIK. Clin Ophthalmol 2014; 8: 35–42. [CrossRef] [PubMed]

18. Probst LE. LASIK: Advances, Controversies and Customs. Thorofare, New Jersey: Slack Incorporated, 2003.

19. Alió JL, Piñero PD, Alesón A, Teus MA, Barraquer RI, Murta J, Maldonado MJ, etal. Keratoconus-integrated characterization considering anterior corneal aberrations, internal astigmatism, and corneal biomechanics. J Cataract Refract Surg 2011; 37: 552–68. [CrossRef] [PubMed]

20. Kozobolis V, Sideroudi H, Giarmoukakis A, Gkika M, Labiris G. Corneal biomechanical properties and anterior segment parameters in formefruste keratoconus. Eur J Ophthalmol 2012; 22: 920–30.  [CrossRef] [PubMed]

21. Nettune GR, Pflugfelder SC. Post-LASIK tear dysfunction and dysesthesia. Ocul Surf  2010; 8: 135145. [CrossRef] [PubMed]

22. Shtein, RM. Post-LASIK dry eye. Expert Rev Ophthalmol 2011; 6: 57582. [CrossRef] [PubMed]

23. Feng YF, Yu JG, Wang DD, Li JH, Huang JH, Shi JL, Ye T, etal. The effect of hinge location on corneal sensation and dry eye after LASIK: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 2013; 251: 35766. [CrossRef] [PubMed]

24. Murakami Y. Manche EE. Prospective, randomized comparison of self-reported postoperative dry eye and visual fluctuation in LASIK and photorefractive keratectomy. Ophthalmology 2012; 119: 2220–24. [CrossRef] [PubMed]

25. Dooley I, D'Arcy F, O'Keefe M. Comparison of dry-eye disease severity after laser in situ keratomileusis and laser-assisted subepithelial keratectomy. J Cataract Refract Surg 2012; 38: 105864. [CrossRef] [PubMed]

26. Cobo-Soriano, R, Beltran J, Baviera J. LASIK outcomes in patients with underlying systemic contraindications: a preliminary study. Ophthalmology 2006; 113:1118 e1–8. [CrossRef] [PubMed]

27. Mohammadpour M. Excimer laser refractive surgery in patients with underlying autoimmune diseases. J Cataract Refract Surg 2007; 33: 175–6. [CrossRef] [PubMed]

28. Liang L, Zhang M, Zou W, Liu Z. Aggravated dry eye after laser in situ keratomileusis in patients with Sjögren syndrome. Cornea 2008; 27:120–3. [CrossRef] [PubMed]

29. Xu KMcKee HDJhanji V. Changing perspective of reasons for not performing laser-assisted in situ keratomileusis among candidates in a university eye clinic. Clin Exp Optom  2013; 96: 20–4.  [CrossRef] [PubMed]

30. Torricelli AA, Bechara SJ, Wilson SE. Screening of refractive surgery candidates for LASIK and PRK. Cornea  2014; 33: 1051–5. [CrossRef] [PubMed]

31. Sharma NSinghvi ASinha RVajpayee RB. Reasons for not performing LASIK in refractive surgery candidates. J Refract Surg 2005; 21: 496–8. [CrossRef] [PubMed]

32. Bamashmus M, Saleh MF, Abdulrahman M, Al-Kershy N. Reasons for not performing LASIK in refractive surgery candidates in Yemen. Eur J Ophthalmol 2010; 20: 858–64.  [CrossRef] [PubMed]

Objavljeno
2023/04/11
Rubrika
Originalni rad